Patient portal

Koen de Bruin

Koen is a postdoctoral researcher specializing in therapeutic immunomodulation through nanomedicine, aiming to reprogram the patient’s own immune system to more effectively combat high-grade brain tumors. These tumors typically exhibit a highly immunosuppressive microenvironment, maintained by tumor-reprogrammed myeloid cells. By targeting these cells and their progenitors with myeloid-specific apolipoprotein nanoparticles, we can deliver immunostimulatory molecules such as trained immunity inducers or mRNA encoding proinflammatory cytokines. Through the use of these advanced nanotherapeutic approaches, we strive to enhance current immunotherapy strategies for the treatment of high-grade brain tumors.